Omada Health, Inc. (OMDA) stock analysis
Healthcare · Health Information Services
From the 10-K filed 2026-03-06
How it makes money
It sells virtual care programs to employers, health plans, and other entities that cover the cost for members.
It delivers virtual care between doctor's visits through a human-led, technology-enabled care model called Compassionate Intelligence. It sells these programs to customers that cover the cost for covered individuals, either by contracting directly or by arranging access through channel partners who resell the programs to their own end customers. Revenue is driven by the volume of member enrollment and the retention and expansion of these customer and channel partner relationships over time.
Its offerings span cardiometabolic programs for prediabetes, diabetes, hypertension, and high cholesterol, alongside physical therapy and behavioral health support. Profitability depends heavily on maintaining member engagement, such as app logins or recording health metrics, and achieving clinical outcomes and cost savings that justify the program costs to the entities paying for them.
What protects it: the moat
It differentiates through clinical rigor, proprietary technology, and a multi-condition platform that addresses high rates of comorbidities.
It relies on clinical research, third-party accreditations, and its proprietary Care Team Platform to build credibility and scale operations. Management claims that its platform and integrated approach create competitive advantages, though the market is new, rapidly evolving, and increasingly competitive.
What growth costs
It incurs significant upfront costs to establish customer relationships, scale Care Teams, and invest in technology.
The filing notes that it incurs significant upfront costs in establishing and expanding relationships with employers, health plans, PBMs, health systems, and government entities. It also needs to increase the size of its organization, including its Care Teams, and invest across data, analytics, operations, and customer success capabilities to support its go-to-market approach. The text does not disclose specific dollar figures for maintaining versus growing these investments.
What could damage it
Concentration among reseller partners and dependence on their growth can reduce customer access and impair revenue.
A substantial portion of sales comes through a limited number of channel partners that operate as resellers. If an end customer no longer works with a particular channel partner, that customer's ability to continue purchasing the programs can be limited, directly reducing member enrollment and revenue.
About Omada Health, Inc.
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.